Bavarian Nordic AS

BV3

Company Profile

  • Business description

    Bavarian Nordic AS is a biotechnology company focused on the research, development, manufacturing, and commercialization of life-saving vaccines. The vast majority of the company's revenue is generated in the United States, Germany, and other geographic markets. Its products include Encepur, Jynneos, Rabipur, Vaxchora and Vivotif.

  • Contact

    Philip Heymans Alle 3
    Hellerup2900
    DNK

    T: +45 33268383

    E: [email protected]

    https://www.bavarian-nordic.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2025

    Employees

    1,653

Stocks News & Analysis

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,833.604.900.06%
CAC 407,754.5516.130.21%
DAX 4023,934.13144.020.61%
Dow JONES (US)44,828.53344.110.77%
FTSE 1008,823.2048.510.55%
HKSE24,069.94151.47-0.63%
NASDAQ20,601.10207.971.02%
Nikkei 22539,785.9023.420.06%
NZX 50 Index12,704.4879.81-0.62%
S&P 5006,279.3551.930.83%
S&P/ASX 2008,595.801.90-0.02%
SSE Composite Index3,461.156.360.18%

Market Movers